BMA Response To Government Campaign On Alcohol Units, UK People could be risking their
health and driving over the limit because they don't know how many alcohol units they're consuming. This is why the BMA is backing the Government 'Know Your Limits' campaign, launched in England today (Monday 19 May 2008).BMA Chairman, Dr Hamish Meldrum, commented:"We are very pleased that the Government is trying to raise awareness about alcohol units.
Source: www.medicalnewstoday.comLandmark ATHENA Study With Dronedarone (Multaq(R)) Shows 24% Reduction In Cardiovascular Hospitalisation Or Death In Patients With Atrial Fibrillation Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that findings from the landmark ATHENA study showed dronedarone (Multaq�), a potential therapy for the treatment of patients with atrial fibrillation or atrial flutter, decreased the risk of cardiovascular hospitalisations or death from any cause by a statistically significant 24% (p=0.00000002), meeting the study primary endpoint.
Source: www.medicalnewstoday.comMalpractice Coverage Rates For Massachusetts Physicians Lower Now Than In 1990s, Study Finds Physicians in Massachusetts pay lower premium rates for malpractice coverage than they did in 1990, despite previous claims that high rates are causing them to leave the state, according to a study published in the current issue of
Health Affairs, the Boston Globe reports.
Source: www.medicalnewstoday.comLos Angeles County Supervisor Candidates Discuss Solutions For Reopening King-Harbor As A Full-Service Hospital The Los Angeles Times on Thursday published a question and answer feature with two leading candidates for Los Angeles County supervisor and included the candidates' answers about reopening Martin Luther King Jr.-Harbor Medical Center as a full-service hospital and improving other
health care issues in the county (Los Angeles Times, 4/15).
Source: www.medicalnewstoday.comFDA Delays Application For First Human Trial Of Embryonic Stem Cells The company Geron on Wednesday announced that it has received oral notice from FDA that the agency is delaying a decision on the company's application for the first clinical trial using human embryonic stem cells in humans, Bloomberg/New York Times reports.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 6:00 PM
